{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:31:21Z","timestamp":1773869481862,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5601,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1046\/j.1365-2133.2000.03471.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:26:50Z","timestamp":1047360410000},"page":"913-923","source":"Crossref","is-referenced-by-count":85,"title":["Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases"],"prefix":"10.1093","volume":"142","author":[{"given":"K.","family":"Gr\u00f8nbAEk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.","family":"M\u00d8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nedergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Baadsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hou-Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zeuthen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Guldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"RalfkiAEr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,1,2]]},"reference":[{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB1|cit1","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1046\/j.1365-2133.2000.03471.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000246981","article-title":"Classification of primary cutaneous lymphomas. Historical overview and perspectives","volume":"189","author":"Willemze","year":"1994","journal-title":"Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0560.1997.tb00801.x","article-title":"The Revised European-American Classification of Lymphoid Neoplasms (REAL): a new perspective for the classification of cutaneous lymphomas","volume":"24","author":"Sander","year":"1997","journal-title":"J Cutan Pathol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB4|cit4","first-page":"172","volume-title":"Extranodal Lymphomas (","author":"Isaacson","year":"1994:"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2133.1994.tb08560.x","article-title":"MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease","volume":"131","author":"Slater","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2133.1998.02547.x","article-title":"Primary cutaneous B-cell lymphoma: how useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification?","volume":"139","author":"Russell-Jones","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4613-1261-1_3","article-title":"Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma","volume":"84","author":"Reed","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0968-0004(98)01236-5","article-title":"The INK4a\/ARF tumor suppressor: one gene-two products-two pathways","volume":"23","author":"Chin","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin\u2019s lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","article-title":"Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin\u2019s lymphoma","volume":"90","author":"Koduru","year":"1997","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","article-title":"Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas","volume":"317","author":"Weiss","year":"1987","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1046\/j.1365-2133.2000.03471.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/annonc\/8.suppl_2.S109","article-title":"Bcl-1\/cyclin D1 in malignant lymphoma","volume":"8","author":"de Boer","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/sj.leu.2401090","article-title":"Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb","volume":"12","author":"Gr\u00f8nbaek","year":"1998","journal-title":"Leukemia"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1699-0463.1999.tb01453.x","article-title":"Apoptosis-related genes and proteins in Hodgkin\u2019s disease","volume":"107","author":"Lauritzen","year":"1999","journal-title":"APMIS"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1073\/pnas.85.13.4869","article-title":"Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease","volume":"85","author":"Crescenzi","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ajcp\/103.4.472","article-title":"Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma","volume":"103","author":"Horsman","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0145-2126(94)90026-4","article-title":"ev;18) in subtypes of non-Hodgkin\u2019s lymphomas","volume":"18","author":"Klefstrom","year":"1994","journal-title":"Leuk Res"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1997)9:4<348::AID-HUMU8>3.0.CO;2-1","article-title":"Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer","volume":"9","author":"Guldberg","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB22|cit22","first-page":"150","article-title":"CDKN2\/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated","volume":"56","author":"Ueki","year":"1996","journal-title":"Cancer Res"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nature Genet"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood.V85.4.893.bloodjournal854893","article-title":"Deletions and rearrangement of CDKN2 in lymphoid malignancy","volume":"85","author":"Stranks","year":"1995","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000484740","article-title":"A single-tube PCR test for the diagnosis of Angelman and Prader-Willi syndrome based on allelic methylation differences at the SNRPN locus","volume":"5","author":"Zeschnigk","year":"1997","journal-title":"Eur J Hum Genet"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR. a novel PCR assay for methylation status of CpG islands","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB27|cit27","first-page":"837","article-title":"Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies","volume":"57","author":"Herman","year":"1997","journal-title":"Cancer Res"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nm0795-686","article-title":"5\u2032 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers","volume":"1","author":"Merlo","year":"1995","journal-title":"Nature Med"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0","article-title":"Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases","volume":"67","author":"Santucci","year":"1991","journal-title":"Cancer"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.leu.2400911","article-title":"Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d\u2019\u00c9tude des Lymphomes de l\u2019Adulte","volume":"12","author":"Brice","year":"1998","journal-title":"Leukemia"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-199412000-00001","article-title":"Primary cutaneous large cell lymphomas. Morphologic, immunophenotypic, and clinical features of 20 cases","volume":"18","author":"Kurtin","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2133.1995.tb08703.x","article-title":"Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas","volume":"132","author":"Joly","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","volume":"329","author":"","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archderm.132.11.1304","article-title":"Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group","volume":"132","author":"Vermeer","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2133.1999.02992.x","article-title":"Classification of primary cutaneous B-cell lymphomas: EORTC classification or REAL classification?","volume":"141","author":"Willemze","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0190-9622(97)70090-2","article-title":"Primary cutaneous B-cell lymphoma: a clinically homogeneous entity?","volume":"37","author":"Pimpinelli","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1182\/blood.V86.8.3160.3160","article-title":"Molecular analysis of cutaneous B- and T-cell lymphomas","volume":"86","author":"Neri","year":"1995","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/1523-1747.ep12371768","article-title":"bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas","volume":"102","author":"Cerroni","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00000478-199608000-00010","article-title":"Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients","volume":"20","author":"Bailey","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000478-199802000-00008","article-title":"CD5+ low-grade marginal zone B-cell lymphomas with localized presentation","volume":"22","author":"Ballesteros","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","article-title":"Bcl10 is involved in t(1;14) (p22; q32) of MALT B cell lymphoma and mutated in multiple tumor types","volume":"96","author":"Willis","year":"1999","journal-title":"Cell"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018","article-title":"Somatic Fas mutations in non-Hodgkin\u2019s lymphoma: association with extranodal disease and autoimmunity","volume":"92","author":"Gr\u00f8nbaek","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.1998.16.6.2080","article-title":"bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related","volume":"16","author":"Geelen","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.1993.01680240093016","article-title":"Skin-associated lymphoid tissue (SALT)-related B-cell lymphoma (primary cutaneous B-cell lymphoma). A concept and a clinicopathologic entity","volume":"129","author":"Giannotti","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.1995.01690210049008","article-title":"p53 oncoprotein expression in cutaneous lymphoproliferations","volume":"131","author":"Beylot-Barry","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM199708213370804","article-title":"Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma","volume":"337","author":"Ichikawa","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2133.2000.03471.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.leu.2400579","article-title":"Hypermethylation of a 5\u2032 CpG island of p16 is a frequent event in non-Hodgkin\u2019s lymphoma","volume":"11","author":"Martinez Delgado","year":"1997","journal-title":"Leukemia"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2000.03471.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:29:05Z","timestamp":1676377745000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/142\/5\/913\/6689646"}},"subtitle":["PRIMARY CUTANEOUS B-CELL LYMPHOMA"],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03471.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}